SEC Form 4 · accession 0000905148-26-003055
MAXCYTE, INC. · MXCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rekha Hemrajani
Director
Period of report
Jun 17, 2026
Accepted (ET)
Jun 22, 2026 · 4:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001287098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 17, 2026 | A | 30,421 | $0.00 | A | 70,314 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.13 | Jun 17, 2026 | A | 49,579 | A | — | Jun 16, 2036 | Common Stock | 49,579 | 49,579 | D |
Explanation of responses
- F1These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- F2This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date.